November 30, 2020
Zomedica (ZOM) penny stock is surging right now. It was 13 cents before opening this morning. Now it’s 15. If any of you see this in real time I believe if it jumps 3 cents its going to skyrocket. I’ll… Continue Reading…
November 13, 2020
“Telephone & Data Systems… This stock also holds a Strong Buy rating from the analyst consensus, based on 3 unanimous Buy reviews set in recent weeks. Shares are priced at $18.73 and the average target of $34.83 suggests a one-year… Continue Reading…
November 2, 2020
“Alliance Data Systems (ADS)… Overall, ADS has a Strong Buy rating from the analyst consensus, based on 5 Buys and 1 Hold. The stock is selling for $53 and its $71.43 average price target implies an upside of ~35% over… Continue Reading…
October 28, 2020
“Chromadex (CDXC)… It’s not often that the analysts all agree on a stock, so when it does happen, take note. CDXC’s Strong Buy consensus rating is based on a unanimous 3 Buys. The stock’s $7.67 average price target suggests a… Continue Reading…
January 1, 2021
“PayPal said that users on its platform will be able to purchase bitcoin BTCUSD, 0.73%, as well as other sister cryptos like ethereum ETHUSD, 4.79%, bitcoin Cash BCHUSD, 5.59% and Litecoin LTCUSD, 4.24%. That news has helped to drive the value of bitcoin to just under $13,000, marking its highest level since around January… Continue Reading…
October 15, 2020
“Catalyst Biosciences (CBIO)… Other analysts don’t beg to differ. With 3 Buy ratings and no Holds or Sells, the word on the Street is that CBIO is a Strong Buy. At $19.33, the average price target implies 303% upside potential… Continue Reading…
October 6, 2020
“Coster remains positive on Nikola and keeps an Overweight (i.e. Buy) rating along with a bullish $41 price target. The analyst, therefore, expects shares to add nearly 70% from current levels… Nikola appears to be the subject of much head… Continue Reading…
October 1, 2020
“When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards. It was the gamble of… Continue Reading…
September 30, 2020
“Brickell Biotech (BBI)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. As a result, BBI gets a Moderate Buy consensus rating. The $5 average price target is identical… Continue Reading…
September 26, 2020
“NexTier Oilfield Solutions (NEX)… Similarly, the rest of the Street is getting onboard. 6 Buy ratings and 2 Hold assigned in the last three months add up to a Strong Buy analyst consensus. In addition, the $3.70 average price target… Continue Reading…
Recent Comments